Cargando…

IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats

BACKGROUND: Mesenchymal stromal cells (MSCs) activated with IFN-γ elicit stronger physical effects. Exosomes (Exos) secreted from MSCs show protective effects against myocardial injury. This study aimed to determine whether Exos derived from IFN-γ-treated MSCs exhibit more potent cardioprotective fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Lu, Yao, Mao, Yangming, Yu, Yue, Wu, Tianyu, Zhao, Wei, Zhu, Yeqian, Zhao, Pengcheng, Zhang, Fengxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308256/
https://www.ncbi.nlm.nih.gov/pubmed/35870960
http://dx.doi.org/10.1186/s13287-022-02984-z
_version_ 1784752947856408576
author Zhang, Jian
Lu, Yao
Mao, Yangming
Yu, Yue
Wu, Tianyu
Zhao, Wei
Zhu, Yeqian
Zhao, Pengcheng
Zhang, Fengxiang
author_facet Zhang, Jian
Lu, Yao
Mao, Yangming
Yu, Yue
Wu, Tianyu
Zhao, Wei
Zhu, Yeqian
Zhao, Pengcheng
Zhang, Fengxiang
author_sort Zhang, Jian
collection PubMed
description BACKGROUND: Mesenchymal stromal cells (MSCs) activated with IFN-γ elicit stronger physical effects. Exosomes (Exos) secreted from MSCs show protective effects against myocardial injury. This study aimed to determine whether Exos derived from IFN-γ-treated MSCs exhibit more potent cardioprotective function and the underlying mechanisms. METHODS: H9c2 cells or human umbilical vein endothelial cells (HUVECs) were treated with Exos isolated from MSCs (Ctrl-Exo) or IFN-γ-primed MSCs (IFN-γ-Exo) under oxygen and glucose deprivation (OGD) conditions in vitro and in vivo in an infarcted rat heart. RNA sequencing was used to identify differentially expressed functional transcription factors (TFs). Quantitative reverse transcription-PCR (qPCR) was used to confirm the upregulated TFs and miRNA in IFN-γ-primed MSCs. Dual-luciferase reporter gene assay was used to analyze the transcriptional regulation of miRNAs by STAT1. The target of miR-21-5p (miR-21) was determined by luciferase reporter assays and qPCR. The function of BTG2 was verified in vitro under OGD conditions. RESULT: IFN-γ-Exo accelerated migration and tube-like structure formation and prevented OGD-induced apoptosis in H9c2. Similarly, IFN-γ-Exo treatment caused a decrease in fibrosis, reduced cardiomyocyte apoptosis, and improved cardiac function compared to Ctrl-Exo treatment. MiR-21 was significantly upregulated in IFN-γ-primed MSCs and IFN-γ-Exo. STAT1 transcriptionally induced miR-21 expression. Up-regulated miR-21 could inhibit BTG anti-proliferation factor 2 (BTG2) expressions. BTG2 promoted H9c2 cell apoptosis and reversed the protective effects of miR-21 under OGD conditions. CONCLUSION: IFN-γ-Exo showed enhanced therapeutic efficacy against acute MI, possibly by promoting angiogenesis and reducing apoptosis by upregulating miR-21, which directly targeted BTG2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02984-z.
format Online
Article
Text
id pubmed-9308256
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93082562022-07-24 IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats Zhang, Jian Lu, Yao Mao, Yangming Yu, Yue Wu, Tianyu Zhao, Wei Zhu, Yeqian Zhao, Pengcheng Zhang, Fengxiang Stem Cell Res Ther Research BACKGROUND: Mesenchymal stromal cells (MSCs) activated with IFN-γ elicit stronger physical effects. Exosomes (Exos) secreted from MSCs show protective effects against myocardial injury. This study aimed to determine whether Exos derived from IFN-γ-treated MSCs exhibit more potent cardioprotective function and the underlying mechanisms. METHODS: H9c2 cells or human umbilical vein endothelial cells (HUVECs) were treated with Exos isolated from MSCs (Ctrl-Exo) or IFN-γ-primed MSCs (IFN-γ-Exo) under oxygen and glucose deprivation (OGD) conditions in vitro and in vivo in an infarcted rat heart. RNA sequencing was used to identify differentially expressed functional transcription factors (TFs). Quantitative reverse transcription-PCR (qPCR) was used to confirm the upregulated TFs and miRNA in IFN-γ-primed MSCs. Dual-luciferase reporter gene assay was used to analyze the transcriptional regulation of miRNAs by STAT1. The target of miR-21-5p (miR-21) was determined by luciferase reporter assays and qPCR. The function of BTG2 was verified in vitro under OGD conditions. RESULT: IFN-γ-Exo accelerated migration and tube-like structure formation and prevented OGD-induced apoptosis in H9c2. Similarly, IFN-γ-Exo treatment caused a decrease in fibrosis, reduced cardiomyocyte apoptosis, and improved cardiac function compared to Ctrl-Exo treatment. MiR-21 was significantly upregulated in IFN-γ-primed MSCs and IFN-γ-Exo. STAT1 transcriptionally induced miR-21 expression. Up-regulated miR-21 could inhibit BTG anti-proliferation factor 2 (BTG2) expressions. BTG2 promoted H9c2 cell apoptosis and reversed the protective effects of miR-21 under OGD conditions. CONCLUSION: IFN-γ-Exo showed enhanced therapeutic efficacy against acute MI, possibly by promoting angiogenesis and reducing apoptosis by upregulating miR-21, which directly targeted BTG2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-022-02984-z. BioMed Central 2022-07-23 /pmc/articles/PMC9308256/ /pubmed/35870960 http://dx.doi.org/10.1186/s13287-022-02984-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Jian
Lu, Yao
Mao, Yangming
Yu, Yue
Wu, Tianyu
Zhao, Wei
Zhu, Yeqian
Zhao, Pengcheng
Zhang, Fengxiang
IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats
title IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats
title_full IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats
title_fullStr IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats
title_full_unstemmed IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats
title_short IFN-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via miR-21 in myocardial infarction rats
title_sort ifn-γ enhances the efficacy of mesenchymal stromal cell-derived exosomes via mir-21 in myocardial infarction rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308256/
https://www.ncbi.nlm.nih.gov/pubmed/35870960
http://dx.doi.org/10.1186/s13287-022-02984-z
work_keys_str_mv AT zhangjian ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT luyao ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT maoyangming ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT yuyue ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT wutianyu ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT zhaowei ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT zhuyeqian ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT zhaopengcheng ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats
AT zhangfengxiang ifngenhancestheefficacyofmesenchymalstromalcellderivedexosomesviamir21inmyocardialinfarctionrats